Skip to content

Clinical trials

Phase 3 Macular Edema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Phase: Phase 3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20092
20111
20151
20161
20172
20182
20193
20203
20213
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated7
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kodiak Sciences Inc5
Novartis Pharmaceuticals4
Allergan2
Clearside Biomedical, Inc.2
Hoffmann-La Roche2
JHSPH Center for Clinical Trials2
Merck Sharp & Dohme LLC2
AbbVie1
Alcon Research1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema26
Retinal Vein Occlusion14
Diabetic Retinopathy7
Vision Disorders5
Eye Diseases3
Retinal Degeneration3
Retinal Diseases3
Vision, Low3
Diabetes Mellitus2
Uveitis2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.